Manish Gupta*
Professor and Head, Department of Otorhinolaryngology and Head Neck Surgery, MMIMSR, MMDU, Mullana, Ambala, Haryana, India
*Corresponding Author: Manish Gupta, Professor and Head, Department of Otorhinolaryngology and Head Neck Surgery, MMIMSR, MMDU, Mullana, Ambala, Haryana, India.
Received: May 13, 2021; Published: 00-00
Mucormycosis is an invasive fungal infection of nose and paranasal sinuses by fungi from family Mucoracea, is usually seen in diabetic and immunocompromised patients. In patients with COVID-19, the early start of high dose steroids even in mild stage, the use of immunomodulators (Tocilizumab), longstanding oxygen therapy and previous uncontrolled diabetes mellitus are the important factors predisposing to this fulminant infection.
Citation: Manish Gupta. “Rhino-Orbital-Cerebral Mucormycosis: Battle for Life Continues, Post-COVID". Acta Scientific Otolaryngology 3.7 (2020): 01.
Copyright: © 2021 Manish Gupta. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.